Aptose Biosciences Financial Overview
Aptose Biosciences's market cap is currently $3.62M. The company's EPS TTM is $-2.01; its P/E ratio is -0.08; Aptose Biosciences is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
